Maximum daily dose should not exceed 3,000 mg, with caution in patients with liver disease or alcohol use
ALA is able to form a lipophilic complex with Cu 2+ and protect against Cu 2+ -induced lipid peroxidation
DSIP provides a regulatory signal while you're using it
But for the patient sitting in front of me today, I need a drug I can prescribe, that they can fill at their pharmacy, and that their insurance will cover." Switching from Liraglutide to Retatrutide No clinical protocol exists for switching between these two agents because retatrutide is not yet approved
Certain thyroid conditions carry additional considerations: people with a history of medullary thyroid cancer or MEN syndrome cannot use GLP-1 medications due to FDA warnings
Myo-inositol is best known for its role in PCOS, but a smaller body of research has looked at it in non-PCOS women undergoing IVF